09/04/2009 - News

FDA Issues Warning about Stolen Insulin

By: June Chen, MD

Tools:

TheU.S. Food and Drug Administration (FDA) has issued a reminder to the public that stolen vials of the long-acting insulin Levemir, manufactured by Novo Nordisk, may still be on the market and this insulin may be harmful if used 

The FDA first alerted the public to the insulin theft in June 2009, when three lots of Levemir containing a total of 129,000 vials of insulin were stolen in North Carolina. To date, only 2 percent of the stolen insulin has been recovered. Based on the current evidence, the stolen insulin was not stored and handled in the proper fashion, so it may be dangerous for diabetics to use. The FDA indicates that it has received multiple reports of patients who suffered from adverse events related to poor blood sugar control after using a vial of the stolen insulin.

 
The stolen insulin lot numbers are XZF0036, XZF0037, and XZF0038. Diabetics who are in possession of insulin vials from these lot numbers should not use them. The lot number can be found on the side of the insulin box and on the vial itself. The FDA is continuing to investigate the theft and is asking for the public’s help in reporting information about any of these stolen insulin vials to the FDA’s Office of Criminal Investigations by calling 800-551-3989 or by visiting the OCI website.
 

Source:

U.S. Food and Drug Administration news release, August 26, 2009.

Created on: 09/04/2009
Reviewed on: 09/04/2009

No votes yet
Tools: